What Happened? Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 24.1% in the afternoon session after ...

Fortrea Completes Expansion of Clinical Pharmacology Solutions Following Targeted Investments at its Four Clinical Research Units in U.S. and U.K. Fortrea Holdings Inc Thu, Nov 2, 2023, 7:00 AM 5 ...

Adds speed and agility with cGMP production at on-site pharmacies, adds capacity, improves flexible therapeutic capabilities and enhances experience for study volunteersDURHAM, N.C., Nov. 02, 2023 ...

BURLINGTON – Life science giant Labcorp will call its looming spinoff Fortrea, its focus being clinical trials around the world and with 19,000 employees. The company announced the name early ...

Fortrea, the CRO that spun out of Labcorp last year, is linking up with trial software provider Veeva Systems and regulatory review company Advarra to leverage their services in an effort to ...

Collaboration leverages Medidata AI to improve access and participation of diverse population groups in clinical studiesDURHAM, N.C., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a ...

Diversity in clinical trials has long been an issue due to a lack of communication and trust with minority communities. Mark Morais, Fortrea’s COO and President of Clinical Services, and Fareed ...

Potential Positives. Fortrea's sponsorship of the SCRS Collaborate Forward working group highlights its commitment to reducing administrative burdens in clinical research, showcasing the company's ...

The expansion includes a 100,000 square feet state-of-the-art facility in Leeds, U.K. as well as approximately 20,000 square feet of new or renovated space, adding capacity and capabilities across ...

DURHAM, N.C., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced a partnership with Medidata, a Dassault Systèmes ...

KUALA LUMPUR, Nov 3 (Bernama) -- Fortrea, a global contract research organisation (CRO), has completed a multi-year effort to expand its clinical pharmacology solutions and capacity, which are now ...